ROTTERDAM (the Netherlands) and SAN DIEGO (US), July 25th, 2019: hematologists and multiple myeloma (blood cancer) patients in the UK will have access to Dutch developed diagnostic test MMprofilerTM with SKY92 algorithm through the diagnostic service provided by Everything Genetic Ltd. SkylineDx, the diagnostics company that developed the test, announced today its collaboration with the UK based provider of a genetic testing service.
A substantial number of multiple myeloma patients could make more informed decisions on their treatment if more information about their disease prognosis becomes available for them and their treating physician. The MMprofilerTM with SKY92 algorithm is able to assign this risk profile to an individual patient at moment of diagnosis in a reliable, robust and standardized manner. “As we have launched our test as standard clinical practice in The Netherlands, our next aim is to make the test available for all patients in the UK”, says Dharminder Chahal, CEO SkylineDx. “Everything Genetic Ltd has been a great sparring partner leading up to our introduction on the UK market. I have full confidence in James Price and his team’s knowledge to transit our diagnostic service outside of clinical trials into the daily practice”.
“The MMprofiler service offers a rapid and best in class prognostic tool for all Myeloma patients. With this Service we hope to be a key part in transforming care in an area that is desperately in need of more accurate therapy choice. Early discussions with key oncologist and payors are positive, and the EGL team are very excited to be part of bringing this next generation service to the UK”, concludes James Price, CEO and founder Everything Genetic Ltd.
About Everything Genetic Ltd
Everything Genetic Ltd enables diagnostic, prognostic and theranostic-focused companies to rapidly assess and gain access to the UK IVD markets. We cover breast, ovarian, colorectal, urological and hematologic cancers. We offer simple business consultancy-based support or deeper level distributor sales support or a combination of the two. Everything Genetic Ltd offers a solution to many of the issues facing patients and health professionals alike. More information at www.everythinggeneticltd.co.uk.
About SkylineDx
SkylineDx is a high-tech commercial-stage biotech company headquartered in Rotterdam, The Netherlands and a commercial office and CAP/CLIA certified laboratory in San Diego, California, USA. The company uses its expertise to bridge the gap between academically discovered gene expression signatures and commercially available diagnostic products with high clinical utility. With the focus on diagnostics, SkylineDx assists healthcare professionals in accurately determining the type or status of the disease or to predict a patient’s response to a specific treatment. Based on the test results, healthcare professionals can tailor the treatment to the individual patient. To learn more, please visit www.skylinedx.com.
